$BPTH
BIO-PATH HOLDINGS, INC.

2018 Q1 Form 10-Q Financial Statement

#000114420418028882 Filed on May 15, 2018

View on sec.gov

Income Statement

Concept 2018 Q1 2017 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $990.0K $970.0K
YoY Change 2.06% 14.12%
% of Gross Profit
Research & Development $932.0K $1.026M
YoY Change -9.16% 0.59%
% of Gross Profit
Depreciation & Amortization $66.00K $33.00K
YoY Change 100.0% 230.0%
% of Gross Profit
Operating Expenses $1.919M $1.996M
YoY Change -3.86% 6.8%
Operating Profit -$1.919M -$1.996M
YoY Change -3.86% 6.8%
Interest Expense $0.00 $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $3.000K $1.599M
YoY Change -99.81% 79850.0%
Pretax Income -$1.920M -$400.0K
YoY Change 380.0% -78.61%
Income Tax
% Of Pretax Income
Net Earnings -$1.916M -$397.0K
YoY Change 382.62% -78.74%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$3.368M -$833.3K
COMMON SHARES
Basic Shares Outstanding 95.65M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q1 2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.280M $7.110M
YoY Change -39.8% 9.89%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets $1.590M $1.240M
YoY Change 28.23% -8.82%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $5.870M $8.350M
YoY Change -29.7% 6.64%
LONG-TERM ASSETS
Property, Plant & Equipment $605.0K $872.0K
YoY Change -30.62% 1306.45%
Goodwill
YoY Change
Intangibles $889.0K
YoY Change -15.33%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.330M $1.760M
YoY Change -24.43% 57.71%
TOTAL ASSETS
Total Short-Term Assets $5.870M $8.350M
Total Long-Term Assets $1.330M $1.760M
Total Assets $7.200M $10.11M
YoY Change -28.78% 13.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $140.0K $90.00K
YoY Change 55.56% -55.22%
Accrued Expenses $790.0K $610.0K
YoY Change 29.51% -12.73%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $930.0K $710.0K
YoY Change 30.99% -21.11%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.310M
YoY Change
Total Long-Term Liabilities $0.00 $1.310M
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $930.0K $710.0K
Total Long-Term Liabilities $0.00 $1.310M
Total Liabilities $930.0K $2.020M
YoY Change -53.96% 124.44%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $6.275M $8.090M
YoY Change
Total Liabilities & Shareholders Equity $7.200M $10.11M
YoY Change -28.78% 12.96%

Cashflow Statement

Concept 2018 Q1 2017 Q1
OPERATING ACTIVITIES
Net Income -$1.916M -$397.0K
YoY Change 382.62% -78.74%
Depreciation, Depletion And Amortization $66.00K $33.00K
YoY Change 100.0% 230.0%
Cash From Operating Activities -$1.664M -$1.840M
YoY Change -9.57% -22.69%
INVESTING ACTIVITIES
Capital Expenditures $17.00K $424.0K
YoY Change -95.99%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$17.00K -$424.0K
YoY Change -95.99%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -1.664M -$1.840M
Cash From Investing Activities -17.00K -$424.0K
Cash From Financing Activities 0.000
Net Change In Cash -1.681M -$2.264M
YoY Change -25.75% -4.87%
FREE CASH FLOW
Cash From Operating Activities -$1.664M -$1.840M
Capital Expenditures $17.00K $424.0K
Free Cash Flow -$1.681M -$2.264M
YoY Change -25.75%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
138000 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1664000 USD
CY2017Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
40000 USD
CY2017Q1 us-gaap Depreciation
Depreciation
33000 USD
CY2017Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1000 USD
CY2017Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-40000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1840000 USD
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
424000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-424000 USD
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-1916000 USD
CY2018Q1 us-gaap Depreciation
Depreciation
66000 USD
CY2018Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
139000 USD
CY2018Q1 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-1681000 USD
CY2018Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17000 USD
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0259 pure
CY2017Q4 us-gaap Other Inventory
OtherInventory
1100000 USD
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0209 pure
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.95 pure
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1 pure
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-17000 USD
CY2018Q1 us-gaap Share Based Compensation
ShareBasedCompensation
124000 USD
CY2017Q1 us-gaap Share Based Compensation
ShareBasedCompensation
249000 USD
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
1919000 USD
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
1996000 USD
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1996000 USD
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.17
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2018Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
11341000 shares
CY2017Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
9565000 shares
CY2018Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
3000 USD
CY2017Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
3000 USD
CY2018Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3000 USD
CY2017Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1599000 USD
CY2016Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
588235000 shares
CY2016Q2 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
9300000 USD
CY2017Q2 bpth Class Of Warrant Or Right Exercisable Number
ClassOfWarrantOrRightExercisableNumber
441176000 shares
CY2017Q2 bpth Class Of Warrant Or Right Exercised Number
ClassOfWarrantOrRightExercisedNumber
11176000 shares
CY2017Q2 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1500000 USD
CY2018Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
400000 USD
CY2018Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-400000 USD
CY2018Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
-200000 USD
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
1000000 USD
CY2017Q4 bpth Accrued Clinical And Preclinical
AccruedClinicalAndPreclinical
400000 USD
CY2018Q1 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
100000 USD
CY2017Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M6D
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2018Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
11.88
CY2018Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
33000000 USD
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
654000 USD
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
642000 shares
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
641000 shares
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
573000 shares
CY2018Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3000 shares
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.6
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.58
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
10.82
CY2018Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.08
CY2018Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
605000 USD
CY2018Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2018Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2018Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2018Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2018Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11341000 shares
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2018Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11341000 shares
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11339000 shares
CY2018Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0 USD
CY2017Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
114000 USD
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11339000 shares
CY2018Q1 us-gaap Payments To Suppliers
PaymentsToSuppliers
100000 USD
CY2017Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
200000 USD
CY2018Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
800000 USD
CY2018Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y1M6D
CY2018Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
100000 USD
CY2017Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
100000 USD
CY2018Q1 us-gaap Other Commitment Due In Next Twelve Months
OtherCommitmentDueInNextTwelveMonths
700000 USD
CY2018Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-10
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
4000 shares
CY2018Q1 bpth Accrued License Maintenance Fee
AccruedLicenseMaintenanceFee
100000 USD

Files In Submission

Name View Source Status
0001144204-18-028882-index-headers.html Edgar Link pending
0001144204-18-028882-index.html Edgar Link pending
0001144204-18-028882.txt Edgar Link pending
0001144204-18-028882-xbrl.zip Edgar Link pending
bpth-20180331.xml Edgar Link completed
bpth-20180331.xsd Edgar Link pending
bpth-20180331_cal.xml Edgar Link unprocessable
bpth-20180331_def.xml Edgar Link unprocessable
bpth-20180331_lab.xml Edgar Link unprocessable
bpth-20180331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tv493101_10q.htm Edgar Link pending
tv493101_ex31.htm Edgar Link pending
tv493101_ex32.htm Edgar Link pending